Get the Stockscreener App
0.00
100.00%
-10.07
Cantor Equity Partners Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Cantor Equity Partners Inc is a blank check company.
See More
Previous Close:
$10.07
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$128.90M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$10.07
52-Week Range:
$0.00
$10.10
Cantor Equity Partners Inc Stock (CEP) Company Profile
Name
Cantor Equity Partners Inc
Sector
Industry
Phone
-
Address
-
Cantor Equity Partners Inc Stock (CEP) Latest News
Cantor Fitzgerald Affiliated SPAC Files for $200M IPO - MarketWatch
Taxation With Representation: Kirkland, Davis Polk, Wachtell - Law360
FY2024 EPS Estimates for Pfizer Lifted by Cantor Fitzgerald - MarketBeat
Deltec Asset Management LLC Invests $502,000 in Cantor Equity Partners, Inc. Class A Ordinary Shares (NASDAQ:CEP) - MarketBeat
Cantor Fitzgerald Investment Advisors L.P. Invests $5.99 Million in Dollar General Co. (NYSE:DG) - MarketBeat
Cantor Fitzgerald Investment Advisors L.P. Has $3.26 Million Stock Position in M&T Bank Co. (NYSE:MTB) - MarketBeat
Analysts Offer Predictions for KROS FY2024 Earnings - Defense World
SHOREHAVEN MIXED-USE DEVELOPMENT TOPS OUT IN TEMPE - PR Newswire
Cantor Fitzgerald Weighs in on KROS FY2024 Earnings - Defense World
Cantor Fitzgerald Reaffirms Neutral Rating for Tesla (NASDAQ:TSLA) - Defense World
Western Digital (NASDAQ:WDC) PT Raised to $95.00 at Cantor Fitzgerald - Defense World
Keros Therapeutics (NASDAQ:KROS) Now Covered by Cantor Fitzgerald - Defense World
Cantor Fitzgerald Lowers Alkermes (NASDAQ:ALKS) Price Target to $43.00 - MarketBeat
Pfizer (NYSE:PFE) Earns Overweight Rating from Cantor Fitzgerald - MarketBeat
Cantor Fitzgerald Initiates Coverage of LeMaitre Vascular (LMAT) with Neutral Recommendation - MSN
Micron Technology (MU-Q) QuotePress Release - The Globe and Mail
UnitedHealth price target raised to $644 from $591 at Cantor Fitzgerald - Yahoo Finance
Cantor Fitzgerald Comments on Organogenesis Holdings Inc.'s FY2024 Earnings (NASDAQ:ORGO) - MarketBeat
Cantor Fitzgerald Upgrades Teradyne, Inc. (TER) to Overweight as CEO Highlights Surge in Demand for Automated Test Equipment Driven by Cloud AI Products - Yahoo Finance
Brokers Issue Forecasts for Meta Platforms, Inc.’s FY2024 Earnings (NASDAQ:META) - Defense World
Novo Nordisk A/S (NYSE:NVO) Given "Overweight" Rating at Cantor Fitzgerald - MarketBeat
Cantor Fitzgerald Reaffirms "Overweight" Rating for Alkermes (NASDAQ:ALKS) - MarketBeat
Lucid Group (NASDAQ:LCID) Earns Neutral Rating from Cantor Fitzgerald - Defense World
Zillow Group (NASDAQ:ZG) Earns Neutral Rating from Cantor Fitzgerald - MarketBeat
Cantor Fitzgerald Reiterates Neutral Rating for Spotify Technology (NYSE:SPOT) - MarketBeat
GoDaddy (NYSE:GDDY) Stock Rating Reaffirmed by Cantor Fitzgerald - MarketBeat
FY2024 Earnings Forecast for nLIGHT, Inc. Issued By Cantor Fitzgerald (NASDAQ:LASR) - Defense World
Cantor Fitzgerald Reiterates Overweight Rating for Surgery Partners (NASDAQ:SGRY) - MarketBeat
R1 RCM (NASDAQ:RCM) Stock Rating Reaffirmed by Cantor Fitzgerald - Defense World
Cantor Fitzgerald Upgrades Teradyne, Inc. (TER) to Overweight, Citing Strong AI Leverage and Industry Recovery Potential - Yahoo Finance
Vera Therapeutics (NASDAQ:VERA) Receives “Overweight” Rating from Cantor Fitzgerald - Defense World
Cantor Fitzgerald Reiterates “Neutral” Rating for Humana (NYSE:HUM) - Defense World
ICR, the Leading SPAC Communications and Advisory Firm, Publishes its SPAC Market Update & Outlook - Business Wire
Pinterest (NYSE:PINS) Rating Reiterated by Cantor Fitzgerald - MarketBeat
eBay (NASDAQ:EBAY) Stock Rating Reaffirmed by Cantor Fitzgerald - MarketBeat
Amgen initiated with an Overweight at Cantor Fitzgerald - Yahoo Finance
Amgen (NASDAQ:AMGN) Now Covered by Analysts at Cantor Fitzgerald - MarketBeat
Gilead Sciences, Inc. (NASDAQ:GILD) to Post FY2024 Earnings of $3.89 Per Share, Cantor Fitzgerald Forecasts - MarketBeat
Smartsheet to Be Bought in $8.4 Billion Deal. The Stock Is Rising. - MSN
MercadoLibre (NASDAQ:MELI) Rating Reiterated by Cantor Fitzgerald - Defense World
Innoviz Technologies (NASDAQ:INVZ) Earns “Overweight” Rating from Cantor Fitzgerald - Defense World
Cantor Fitzgerald Reaffirms Overweight Rating for Meta Platforms (NASDAQ:META) - MarketBeat
eBay's (EBAY) "Neutral" Rating Reiterated at Cantor Fitzgerald - MarketBeat
Shopify’s (SHOP) Neutral Rating Reiterated at Cantor Fitzgerald - Defense World
Codexis (NASDAQ:CDXS) Stock Rating Reaffirmed by Cantor Fitzgerald - Defense World
Humana (NYSE:HUM) Receives Neutral Rating from Cantor Fitzgerald - Defense World
Cantor Fitzgerald Reiterates “Overweight” Rating for Rivian Automotive (NASDAQ:RIVN) - Defense World
Aurinia Pharmaceuticals (NASDAQ:AUPH) Rating Reiterated by Cantor Fitzgerald - Defense World
Eli Lilly and Company (NYSE:LLY) Given Overweight Rating at Cantor Fitzgerald - Defense World
UnitedHealth Group (NYSE:UNH) Given “Overweight” Rating at Cantor Fitzgerald - Defense World
Vera Therapeutics (NASDAQ:VERA) Given “Overweight” Rating at Cantor Fitzgerald - Defense World
Cantor Equity Partners Inc Stock (CEP) Financials Data
There is no financial data for Cantor Equity Partners Inc (CEP). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.10%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):